The Trump administration reportedly is nearing completion of a new immigration rule that healthcare providers and plans fear will harm public health and their ability to serve millions of low-income children and families.
The CMS' move to allow Medicare Advantage plans to require patients to try low-cost generic drugs before more expensive therapies on Part B could lead to poor health outcomes, causing an increase in ED use and inpatient admissions, providers say.
Advocacy groups sued to block Arkansas' Medicaid work requirement in federal court, two months after they won a federal ruling halting Kentucky's similar waiver program.
In an effort to encourage ACOs to take on downside risk earlier, it plans to end the Track 1 upside-risk-only model.
It's hard to believe it, but for many kids, summer will come to an end in the coming weeks. As parents bulk up on school supplies, it's also important to remember a visit to the doctor's office for immunizations. After all, August is National Immunization Awareness Month.
While Roe v. Wade will be the hot-button issue in the fight over the next Supreme Court justice, the high court could continue to reshape the broader healthcare landscape if cases on the Affordable Care Act and Medicaid work their way through the courts.
The American Hospital Association in September will launch its Center for Health Innovation, which aims to spread best practices across the membership. AHA Board Chair Nancy Howell Agee has been a key driver behind the association's efforts to address innovation.
A major player in 340B drug discount reforms, Rep. Chris Collins (R-N.Y.) can't serve on the House Energy & Commerce Committee, a key health committee, until federal charges of insider trading are resolved.